COARE Biotechnology's Grant - II Round

COARE Biotechnology raised a round of funding on August 28, 2013. Investors include National Institutes of Health.

COARE Biotechnology is focused on targeting tumor-initiating cells in solid tumor cancers. The company utilizes markers of tissue stem/progenitor cells as therapeutic targets. Utilizing tumor xenograf…

Articles about COARE Biotechnology's Grant - II Round: